Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
Sebastian Stasik, Ralph Naumann(University of Siegen), Sebastian Scholl(Jena University Hospital), Jan‐Niklas Eckardt(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Zdeněk Ráčil(Masaryk University), Regina Herbst(Klinikum Chemnitz), Volker Kunzmann(University of Würzburg), Christoph Schliemann(University Hospital Münster), Andreas Burchert(Philipps University of Marburg), Ulrich Kaiser(University of Applied Sciences Landshut), Richard Noppeney(Essen University Hospital), Hubert Serve(Goethe University Frankfurt), Tim Henrik Brümmendorf, Kerstin Schäfer-Eckart, Andreas Hochhaus, Martin Bornhäuser, Norbert Frickhofen, Christoph Röllig, Andreas Neubauer, Michael Krämer, Björn Steffen, Uwe Platzbecker, Martina Crysandt, Martin Kaufmann, Gerhard Ehninger, Christian Thiede, Stefan Krause, Alwin Krämer, Carsten Müller-Tidow, Mathias Hänel, Claudia D. Baldus, Wolfgang E. Berdel, Hermann Einsele, Jiri Mayer, Johannes Schetelig(University Hospital Carl Gustav Carus), Jan M. Middeke, Markus Schaich(Rems-Murr-Klinikum)
RWTH Publications (RWTH Aachen)
January 1, 2021
Cited by 0
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k